CHANDA SANJAY (Chief Development Officer) received a stock award from AN2 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/23/2026ACC: 0001193125-26-064141
Officer· Chief Development Officer
Since Mar 2022
+115K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
115K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38K
Price / share
—
Trade value
—
% of position
47.0%
2/20/2026
80.82K→118.82K
Total
Net shares
+38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | A · Award | +38K | — | — | 47.0% | 80.82K | 118.82K |
| Total | +38K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
77K shares
Shares
+77K
Strike price
1.04
Held after
77K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock77K shares | 2/20/2026 | A · Award | +77K | 1.04 | — | 77K |